M. Cortellaro

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.

M. Cortellaro, E. Cofrancesco, Carla Boschetti et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1993 · 198 citations · Full text

The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.

M. Cortellaro, Carla Boschetti, E. Cofrancesco et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1992 · 189 citations · Full text

Vascular Disease, Pathology, Coronary Artery Disease +22

Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose‐free crystalloid medium

Francesco Bertolini, Paolo Rebulla, D. Riccardi et al. · Transfusion · 1989 · 116 citations

Thrombopoiesis, Thrombosis, Food Colloid +14

Liver dysfunction rather than intravascular coagulation as the main cause of low protein C and antithrombin III in acute leukemia

Francesco Rodeghiero, PM Mannucci, S. Viganò et al. · Blood · 1984 · 96 citations